Предварительные результаты коррекции когнитивно-мнестических нарушений у пациентов с энцефалопатией различного генеза при применении Кавинтона

Abstract

Study design: longitude, open-group, cohort, prospective study in parallel groups to evaluate the efficacy of Cavinton Forte in patients with encephalopathy of different genesis in comparison to standard protocol therapy during 2 month treatment period. 22 patients (11 subjects in control and main groups) underwent 4 visits, during each visit neurological examination was performed, patient underwent testing of cognitive functions with Montreal cognitive assessment (MoCA) and Syndrome short test (SKT), depression level was evaluated with Hamilton depression rate scale (HDRS). According to the results of testing of cognitive-mnestic status patients treated with Cavinton showed significant (p<0,05) positive dynamics at the end of 2 month period, significant differences (p<0,05) between two groups also had been revealed.